BTMD — biote Cashflow Statement
0.000.00%
Last trade - 00:00- $52.21m
- $161.76m
- $192.22m
Annual cashflow statement for biote, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 32.6 | 1.32 | -2.81 | 0.046 | 31.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.16 | 23.9 | 34.9 | 34.6 | 4.11 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.46 | -35.8 | -8.93 | 9.93 | -8.16 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 33.7 | -9.16 | 26.9 | 45.2 | 35.2 |
| Capital Expenditures | -3.81 | -1.84 | -2.71 | -6.96 | -6.86 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -11.8 | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | -3.81 | -1.84 | -2.71 | -18.8 | -6.86 |
| Financing Cash Flow Items | -15.3 | -57.6 | -8.69 | -4.74 | -1.73 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -20.3 | 63.5 | -14.4 | -76.1 | -43.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.56 | 52.5 | 9.77 | -49.7 | -15.2 |